Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04084678 |
| Consolidated Lead Sponsor | United Therapeutics |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 10 participants (ACTUAL) |
| Registered Start Date | 2021-01-20 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora, CO | Open Hospital Dossier -> |
| National Jewish Health | Denver, CO | Open Hospital Dossier -> |
| Princess Alexandra Hospital | Woolloongabba, Australia | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.